Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

NCT00168051 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: ReFacto
DRUG: Advante

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer